Back
CureVac NV 10K Form
Sell
30
CVAC
CureVac NV
Last Price:
2.33
Seasonality Move:
-17.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CVAC News And Ratings
See the #1 stock for the next 7 days that we like better than CVAC
CVAC Financial Statistics
Sales & Book Value
| Annual Sales: | $71.1M |
|---|---|
| Cash Flow: | $-80.26M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.85 |
| Price / Book: | 0.82 |
Profitability
| EPS (TTM): | -1.55200 |
|---|---|
| Net Income (TTM): | $-319.87M |
| Gross Margin: | $-122.94M |
| Return on Equity: | -48.36% |
| Return on Assets: | -33.68% |
CureVac NV Earnings Forecast
Key CureVac NV Financial Ratios
- The Gross Profit Margin over the past 5 years for CVAC is -172.91%.
- The Selling, General & Administrative Expenses for CVAC have been equal to 132.62% of Gross Profit Margin.
- The Research & Development expenses have been 92.78% of Revenue.
- The Interest Expense is -1.49% of Operating Income.
- The Net Earning history of CVAC is -369.37% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 1 years.
CureVac NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CVAC |
| Website: | curevac.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.56 |
| Quick Ratio: | 3.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CVAC Technical Analysis vs Fundamental Analysis
Sell
30
CureVac NV (CVAC)
is a Sell
Is CureVac NV a Buy or a Sell?
-
CureVac NV stock is rated a Sell
The current CureVac NV [CVAC] share price is $2.33. The Score for CVAC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.